All the women in Citron's study received a cocktail of cancer drugs, including Bristol-Myers Squibb 's (nyse: BMY - news - people ) Taxol, Bristol-Myers' Cytoxan and Pharmacia 's (nyse: PHA - news - people ) Adriamycin, all of which are available in generic forms.

FORBES: Magazine Article